{
  "report_rows": [
    {
      "kpi": "International Organic Growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~+1.5% vs. cons -0.87%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "EBITA Margin (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~23.3% vs. cons 23.40%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EPS (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.20 vs. cons $2.21",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adj. EPS (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide $8.70-$8.90 midpoint $8.80 vs. cons $8.77",
      "confidence": "HIGH"
    },
    {
      "kpi": "Organic Growth (FY 2026)",
      "prediction": "LOWER",
      "answer": "guide 2%-4% midpoint 3.0% vs. cons 3.98%",
      "confidence": "HIGH"
    },
    {
      "kpi": "International Recovery Tone (Q3/Q4 qualitative)",
      "prediction": "UNCHANGED",
      "answer": "recovery on track language vs. cons +2.72% Q3 organic",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -3.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -5.0,
  "day5_path": "FADE",
  "day5_rationale": "FADE - organic estimate cuts flow through post-print as sell-side models update; valuation floor (~15x forward P/E) limits damage vs. Q1 2026 episode",
  "day5_confidence": "MEDIUM"
}